A federal district court in Illinois granted in part and denied in part Nexus Pharmaceuticals Inc.'s motion for summary judgment for lack of standing on Ingenus Pharmaceuticals LLC and Leiutis Pharmaceuticals LLP’s action for infringement of a patent that discloses cyclophosphamide liquid formulations. The court determined that Ingenus has constitutional and statutory standing, but it dismissed Leiutis from the case.
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.